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Editorial Comment
Coronary Angioplasty and the
Persistent Problem of Restenosis*
HARVEY G. KEMP, JR., MD, FACC
New York, New York
Less than 10 years ago, transluminal coronary angioplasty
was demonstrated to be a remarkably successful method of
revascularization in coronary heart disease (I). Coronary
bypass surgery had dominated this field for 10 years, and
continuing experience as well as the results of the Coronary
Artery Surgery Study (CASS) had yet to temper the enthu-
siasm of most physicians for this approach (2). It is generally
agreed that, although difficult to quantify, the impact of
angioplasty has been greater than was anticipated (3). Its
major limitation has been an incidence of restenosis varying
from 13 to 47%, and usually occurring within the first 6
months (4,5).
Factors involved in coronary restenosis. Coronary ar-
tery spasm has been observed at the site of prior angioplasty
and has been postulated as a possible contributor to reste-
nosis (6). On this basis, most institutions have treated pa-
tients with calcium channel blockers for 6 weeks to 6 months
after angioplasty. In this issue of the Journal, Whitworth et
al. (7) report that they found no beneficial effect of nifed-
ipine on restenosis after angioplasty. The dose used, 10 mg
orally four times daily, is in the low to middle range. Corcos
et al. (8) previously reported the failure of diltiazem to
prevent restenosis after coronary angioplasty. The dose in
their study, 90 mg three times daily, is in the high range.
These two studies tentatively suggest that 1) treatment with
calcium channel blockers does not decrease the rate of re-
stenosis, and 2) restenosis may not be due to coronary spasm,
because the latter should be affected by these drugs.
One of the large early studies of restenosis came from
the National Heart, Lung, and Blood Institute registry (4)
and was referred to by Whitworth et al. (7). Increased in-
cidence of restenosis was associated with four variables by
multivariate analysis: male sex, angioplasty of bypass graft
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stenosis, severity of angina before angioplasty and absence
of a history of myocardial infarction before angioplasty.
Leimgruber et al. (9) noted that an intimal dissection may
result in a reduced incidence of later restenosis. Austin et
al. (10) examined the coronary arteries of three patients who
died after angioplasty. The area of dilation at 5 days showed
several deep cracks in the plaque with disruption of the
media. Early proliferation of smooth muscle cells was noted
and this was more apparent in patients who died later.
Time course of restenosis. The cause of restenosis may
elude us for some time, but a related issue is receiving
attention: what is the time course of restenosis after coronary
angioplasty? It has long been appreciated that restenosis
occurs in the first 6 months after angioplasty (II). Wijns et
al. (12) recently reported that thallium scintigraphic studies
performed 4 weeks after angioplasty permitted prediction
of 74% of the patients who had angiographically demon-
strated restenosis at 6 months. They proposed that some
degree of restenosis occurs at 4 weeks in most patients in
whom it later becomes manifest. DePuey et al. (13) studied
patients before and after angioplasty with exercise-gated
radionuclide ventriculography. They found that patients with
abnormal findings as early as 4 days after angioplasty had
a significantly higher restenosis rate than those without such
findings. An abnormal radionuclide ventriculogram early
after angioplasty had an accuracy of 73% in predicting 50%
or greater restenosis on follow-up angiography.
Clinical implications. These studies suggest that a pro-
cess may take place very early after angioplasty that di-
minishes coronary reserve and is related to restenosis. This
could be important to the study of restenosis, particularly
in relation to pharmacologic interventions that might modify
the healing process and reduce the rate of restenosis. Cur-
rently, studies of restenosis require patients to be followed
up over 6 months and to be restudied angiographically.
These studies are time-consuming and expensive and in-
volve invasive procedures with their attendant risks.
In addition to their impact on the study of restenosis, the
studies may suggest that pharmacologic treatment should be
early, at high doses and intensive, rather than at medium
doses for weeks to months. It is possible that pretreatment
is essential, as Chesebro et al. (14,15) found in studying
the impact of antiplatelet treatment affecting long-term pat-
ency of saphenous vein grafts. The problem of restenosis
currently represents a major limitation of coronary angio-
plasty. Recent observations may shed light on this process
and make the search for a solution somewhat simpler.
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